Submitted by dcc on Thu, 2017-02-16 13:44 Study Title: Randomized Study of Erlotinib Vs Observation in Patients with Completely Resected Epidermal Growth Factor Receptor (EGFR) Mutant Non-Small Cell Lung Cancer (NSCLC)CIRB: Adult CIRB - Late Phase EmphasisLead Group: AllianceStatus: ActiveReview Status: Available to Open
